BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 66 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,914 | -9.7% | 14,845 | +2.9% | 0.00% | -50.0% |
| Q2 2023 | $236,990 | +0.9% | 14,433 | +2.7% | 0.00% | 0.0% |
| Q1 2023 | $234,798 | -42.9% | 14,052 | -48.6% | 0.00% | 0.0% |
| Q4 2022 | $411,494 | +3.5% | 27,362 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $397,687 | +87.5% | 26,616 | +106.2% | 0.00% | -20.0% |
| Q2 2022 | $212,051 | -15.9% | 12,906 | +2.6% | 0.01% | -16.7% |
| Q1 2022 | $252,000 | -19.2% | 12,577 | +2.2% | 0.01% | -25.0% |
| Q4 2021 | $312,000 | -4.3% | 12,303 | +2.0% | 0.01% | -20.0% |
| Q3 2021 | $326,000 | -5.0% | 12,065 | +1.6% | 0.01% | 0.0% |
| Q2 2021 | $343,000 | +11.4% | 11,877 | +1.6% | 0.01% | 0.0% |
| Q1 2021 | $308,000 | -6.9% | 11,695 | +1.3% | 0.01% | -28.6% |
| Q4 2020 | $331,000 | – | 11,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ PARTNERS, LLC | 169,250 | $4,451,000 | 2.55% |
| Cornerstone Advisors, LLC | 459,157 | $12,076,000 | 1.06% |
| Matisse Capital | 250,000 | $6,574,000 | 0.95% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 45,356 | $1,193,000 | 0.94% |
| 1607 Capital Partners, LLC | 423,925 | $11,149,000 | 0.54% |
| Thomas J. Herzfeld Advisors, Inc. | 33,722 | $887,000 | 0.40% |
| KAVAR CAPITAL PARTNERS GROUP, LLC | 39,750 | $1,045,000 | 0.28% |
| Stockman Wealth Management, Inc. | 20,296 | $534,000 | 0.15% |
| Karpus Management, Inc. | 186,631 | $4,908,000 | 0.15% |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | 100,211 | $2,631,000 | 0.14% |